| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mycobacterium tuberculosis | 97 | 2026 | 424 | 18.670 |
Why?
|
| Tuberculosis | 58 | 2026 | 314 | 11.890 |
Why?
|
| Antitubercular Agents | 13 | 2025 | 85 | 4.830 |
Why?
|
| Bacterial Proteins | 38 | 2025 | 741 | 4.050 |
Why?
|
| Host-Pathogen Interactions | 11 | 2024 | 279 | 3.450 |
Why?
|
| Gene Expression Regulation, Bacterial | 10 | 2025 | 146 | 2.300 |
Why?
|
| Mycobacterium smegmatis | 14 | 2022 | 73 | 2.050 |
Why?
|
| Macrophages | 23 | 2026 | 1041 | 2.020 |
Why?
|
| Cell Wall | 8 | 2022 | 118 | 1.600 |
Why?
|
| Mice | 57 | 2026 | 11174 | 1.570 |
Why?
|
| BCG Vaccine | 11 | 2025 | 57 | 1.520 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2025 | 735 | 1.480 |
Why?
|
| Mycobacterium bovis | 6 | 2024 | 29 | 1.470 |
Why?
|
| Animals | 70 | 2026 | 21467 | 1.450 |
Why?
|
| Genetic Variation | 4 | 2022 | 395 | 1.250 |
Why?
|
| Type VII Secretion Systems | 3 | 2025 | 8 | 1.230 |
Why?
|
| Mycobacterium | 6 | 2017 | 37 | 1.180 |
Why?
|
| Tuberculosis, Pulmonary | 4 | 2018 | 123 | 1.170 |
Why?
|
| Cholesterol | 7 | 2017 | 261 | 1.170 |
Why?
|
| Genes, Bacterial | 6 | 2021 | 115 | 1.150 |
Why?
|
| Iron | 5 | 2024 | 155 | 1.110 |
Why?
|
| Mice, Inbred C57BL | 26 | 2025 | 3501 | 1.080 |
Why?
|
| Peptidoglycan | 7 | 2022 | 55 | 1.070 |
Why?
|
| Genome, Bacterial | 10 | 2025 | 67 | 1.050 |
Why?
|
| DNA Transposable Elements | 13 | 2025 | 160 | 1.020 |
Why?
|
| Bacteria | 5 | 2016 | 337 | 0.970 |
Why?
|
| Tuberculosis Vaccines | 3 | 2024 | 32 | 0.940 |
Why?
|
| Immunity, Innate | 7 | 2026 | 829 | 0.930 |
Why?
|
| Neutrophils | 3 | 2025 | 396 | 0.900 |
Why?
|
| Genetic Fitness | 2 | 2025 | 35 | 0.880 |
Why?
|
| Chromosomes, Bacterial | 4 | 2018 | 44 | 0.870 |
Why?
|
| Genes, Essential | 5 | 2025 | 20 | 0.850 |
Why?
|
| Disease Models, Animal | 13 | 2025 | 2327 | 0.830 |
Why?
|
| Nitric Oxide | 2 | 2017 | 164 | 0.820 |
Why?
|
| Metalloproteases | 1 | 2023 | 4 | 0.790 |
Why?
|
| Carbon | 2 | 2022 | 52 | 0.770 |
Why?
|
| T-Lymphocytes | 5 | 2020 | 1010 | 0.770 |
Why?
|
| Zinc | 2 | 2023 | 95 | 0.760 |
Why?
|
| Peptide Hydrolases | 1 | 2023 | 79 | 0.750 |
Why?
|
| Drug Resistance, Bacterial | 6 | 2025 | 97 | 0.740 |
Why?
|
| Drug Interactions | 1 | 2022 | 126 | 0.700 |
Why?
|
| Immune Evasion | 2 | 2024 | 71 | 0.700 |
Why?
|
| Interleukin-1beta | 4 | 2020 | 274 | 0.700 |
Why?
|
| Cell Cycle | 3 | 2020 | 398 | 0.700 |
Why?
|
| Interferon-gamma | 8 | 2025 | 576 | 0.690 |
Why?
|
| Gene-Environment Interaction | 1 | 2022 | 54 | 0.690 |
Why?
|
| NADPH Oxidase 2 | 2 | 2018 | 36 | 0.690 |
Why?
|
| Electron Transport Complex IV | 1 | 2021 | 16 | 0.690 |
Why?
|
| Genetics, Microbial | 2 | 2018 | 11 | 0.680 |
Why?
|
| Drug Discovery | 6 | 2025 | 96 | 0.660 |
Why?
|
| Mutagenesis, Insertional | 8 | 2017 | 94 | 0.650 |
Why?
|
| Granulocytes | 1 | 2020 | 73 | 0.630 |
Why?
|
| DNA Replication | 3 | 2020 | 250 | 0.630 |
Why?
|
| Cell Division | 2 | 2020 | 451 | 0.610 |
Why?
|
| Glycerol Kinase | 1 | 2019 | 2 | 0.610 |
Why?
|
| Genotype | 6 | 2024 | 674 | 0.590 |
Why?
|
| Anti-Bacterial Agents | 8 | 2021 | 807 | 0.580 |
Why?
|
| Lysine Acetyltransferases | 1 | 2018 | 3 | 0.570 |
Why?
|
| Adenosine Triphosphatases | 6 | 2017 | 256 | 0.560 |
Why?
|
| Lung | 10 | 2025 | 969 | 0.560 |
Why?
|
| Humans | 49 | 2025 | 65654 | 0.540 |
Why?
|
| Microbial Sensitivity Tests | 7 | 2025 | 207 | 0.540 |
Why?
|
| Virulence | 9 | 2024 | 199 | 0.540 |
Why?
|
| Neutrophil Infiltration | 1 | 2018 | 64 | 0.540 |
Why?
|
| Nontuberculous Mycobacteria | 2 | 2019 | 7 | 0.540 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 2 | 2019 | 16 | 0.530 |
Why?
|
| Communicable Diseases | 1 | 2018 | 86 | 0.530 |
Why?
|
| Immune Tolerance | 1 | 2018 | 186 | 0.530 |
Why?
|
| Interleukin-1 | 2 | 2017 | 154 | 0.520 |
Why?
|
| Genome-Wide Association Study | 3 | 2025 | 364 | 0.520 |
Why?
|
| Hypoxia | 1 | 2018 | 121 | 0.520 |
Why?
|
| Genetic Engineering | 3 | 2015 | 114 | 0.480 |
Why?
|
| Interferon Type I | 3 | 2020 | 198 | 0.460 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2024 | 297 | 0.460 |
Why?
|
| Inflammation | 4 | 2020 | 1195 | 0.440 |
Why?
|
| DNA, Recombinant | 1 | 2015 | 47 | 0.430 |
Why?
|
| Mice, Knockout | 10 | 2026 | 2168 | 0.430 |
Why?
|
| Carrier Proteins | 3 | 2023 | 718 | 0.430 |
Why?
|
| Stress, Physiological | 3 | 2013 | 210 | 0.430 |
Why?
|
| Genomics | 4 | 2023 | 386 | 0.420 |
Why?
|
| Antigens, Bacterial | 6 | 2025 | 202 | 0.420 |
Why?
|
| Lipids | 3 | 2025 | 330 | 0.420 |
Why?
|
| Gene Editing | 1 | 2018 | 331 | 0.420 |
Why?
|
| Cell Polarity | 1 | 2014 | 110 | 0.410 |
Why?
|
| Oxidative Stress | 2 | 2015 | 322 | 0.410 |
Why?
|
| Molecular Sequence Data | 12 | 2015 | 1979 | 0.400 |
Why?
|
| Autophagy | 5 | 2025 | 239 | 0.390 |
Why?
|
| Fungi | 1 | 2013 | 57 | 0.380 |
Why?
|
| Genotyping Techniques | 2 | 2024 | 21 | 0.380 |
Why?
|
| Small Molecule Libraries | 2 | 2025 | 57 | 0.370 |
Why?
|
| Sequence Analysis, DNA | 7 | 2025 | 417 | 0.370 |
Why?
|
| Databases, Genetic | 2 | 2025 | 91 | 0.360 |
Why?
|
| Metabolome | 1 | 2012 | 39 | 0.350 |
Why?
|
| Cystic Fibrosis | 1 | 2013 | 126 | 0.350 |
Why?
|
| Immunotherapy | 1 | 2014 | 274 | 0.350 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 404 | 0.350 |
Why?
|
| Signal Transduction | 6 | 2024 | 3164 | 0.350 |
Why?
|
| Nitriles | 2 | 2009 | 82 | 0.340 |
Why?
|
| Th1 Cells | 2 | 2025 | 171 | 0.340 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2020 | 186 | 0.330 |
Why?
|
| Disease Susceptibility | 4 | 2020 | 169 | 0.320 |
Why?
|
| Transcription, Genetic | 5 | 2020 | 909 | 0.310 |
Why?
|
| Pyrazinamide | 2 | 2025 | 9 | 0.310 |
Why?
|
| Selection, Genetic | 1 | 2010 | 90 | 0.310 |
Why?
|
| Ubiquitination | 2 | 2026 | 124 | 0.300 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2025 | 642 | 0.300 |
Why?
|
| Gene Expression Profiling | 6 | 2025 | 797 | 0.290 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2026 | 228 | 0.280 |
Why?
|
| Bacterial Load | 3 | 2020 | 30 | 0.270 |
Why?
|
| Mutation | 11 | 2018 | 2672 | 0.270 |
Why?
|
| Base Sequence | 10 | 2015 | 1331 | 0.270 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2019 | 316 | 0.260 |
Why?
|
| Virulence Factors | 3 | 2024 | 86 | 0.260 |
Why?
|
| Membrane Transport Proteins | 2 | 2020 | 135 | 0.260 |
Why?
|
| Mitochondria | 2 | 2021 | 413 | 0.260 |
Why?
|
| Antibiotics, Antitubercular | 1 | 2007 | 5 | 0.260 |
Why?
|
| Lipid Metabolism | 3 | 2025 | 225 | 0.250 |
Why?
|
| Cytokines | 5 | 2025 | 964 | 0.250 |
Why?
|
| Models, Statistical | 3 | 2019 | 309 | 0.250 |
Why?
|
| Communicable Disease Control | 1 | 2007 | 40 | 0.250 |
Why?
|
| Enzyme Activation | 3 | 2018 | 391 | 0.250 |
Why?
|
| Alleles | 3 | 2024 | 455 | 0.240 |
Why?
|
| DNA, Bacterial | 5 | 2015 | 262 | 0.240 |
Why?
|
| Operon | 4 | 2019 | 31 | 0.230 |
Why?
|
| Gene Library | 5 | 2017 | 102 | 0.230 |
Why?
|
| Fatty Acids | 2 | 2025 | 200 | 0.230 |
Why?
|
| Female | 14 | 2025 | 34310 | 0.220 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2025 | 33 | 0.220 |
Why?
|
| Ligands | 5 | 2023 | 414 | 0.220 |
Why?
|
| INDEL Mutation | 1 | 2025 | 20 | 0.220 |
Why?
|
| Computational Biology | 2 | 2024 | 368 | 0.220 |
Why?
|
| Molecular Structure | 3 | 2018 | 315 | 0.220 |
Why?
|
| Homeostasis | 3 | 2023 | 383 | 0.220 |
Why?
|
| Th17 Cells | 1 | 2025 | 65 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-rel | 2 | 2022 | 16 | 0.220 |
Why?
|
| Phenotype | 2 | 2022 | 1235 | 0.220 |
Why?
|
| Autophagy-Related Protein 7 | 1 | 2024 | 6 | 0.220 |
Why?
|
| Nod2 Signaling Adaptor Protein | 3 | 2009 | 26 | 0.220 |
Why?
|
| Adaptive Immunity | 1 | 2025 | 105 | 0.220 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2025 | 50 | 0.210 |
Why?
|
| Glucans | 1 | 2025 | 66 | 0.210 |
Why?
|
| Mycobacteriaceae | 1 | 2024 | 2 | 0.210 |
Why?
|
| Antibodies, Bacterial | 1 | 2025 | 181 | 0.210 |
Why?
|
| Monocytes | 3 | 2025 | 361 | 0.210 |
Why?
|
| Unfolded Protein Response | 1 | 2025 | 62 | 0.210 |
Why?
|
| Macrophages, Alveolar | 2 | 2024 | 65 | 0.210 |
Why?
|
| Mucins | 2 | 2003 | 27 | 0.210 |
Why?
|
| Adaptation, Physiological | 2 | 2023 | 132 | 0.200 |
Why?
|
| Mutagenesis | 4 | 2023 | 133 | 0.200 |
Why?
|
| Sigma Factor | 1 | 2023 | 7 | 0.200 |
Why?
|
| Phagocytosis | 3 | 2024 | 257 | 0.200 |
Why?
|
| Quantitative Trait Loci | 2 | 2023 | 82 | 0.200 |
Why?
|
| Mycobacterium leprae | 1 | 2003 | 6 | 0.200 |
Why?
|
| Macaca | 2 | 2020 | 30 | 0.200 |
Why?
|
| Bacillus | 1 | 2023 | 15 | 0.190 |
Why?
|
| Cobalt | 2 | 2013 | 18 | 0.190 |
Why?
|
| L-Selectin | 2 | 2003 | 14 | 0.190 |
Why?
|
| Membrane Glycoproteins | 4 | 2020 | 667 | 0.190 |
Why?
|
| Phosphorylation | 5 | 2021 | 963 | 0.190 |
Why?
|
| Gene Expression | 3 | 2020 | 855 | 0.190 |
Why?
|
| Superoxide Dismutase | 2 | 2015 | 223 | 0.190 |
Why?
|
| Copper | 1 | 2023 | 58 | 0.190 |
Why?
|
| Mycolic Acids | 3 | 2020 | 16 | 0.190 |
Why?
|
| Male | 12 | 2025 | 31297 | 0.180 |
Why?
|
| Latent Tuberculosis | 1 | 2023 | 24 | 0.180 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2020 | 300 | 0.180 |
Why?
|
| Cell Respiration | 1 | 2021 | 21 | 0.180 |
Why?
|
| Models, Molecular | 4 | 2021 | 1159 | 0.170 |
Why?
|
| Algorithms | 4 | 2017 | 1052 | 0.170 |
Why?
|
| Drug Delivery Systems | 1 | 2025 | 333 | 0.170 |
Why?
|
| Transcriptome | 1 | 2025 | 405 | 0.170 |
Why?
|
| Reactive Oxygen Species | 3 | 2021 | 237 | 0.170 |
Why?
|
| Sirtuin 3 | 1 | 2021 | 11 | 0.170 |
Why?
|
| Vaccination | 2 | 2024 | 388 | 0.170 |
Why?
|
| Antigen-Presenting Cells | 1 | 2021 | 180 | 0.170 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2021 | 42 | 0.160 |
Why?
|
| Myelopoiesis | 1 | 2020 | 13 | 0.160 |
Why?
|
| Guanosine | 1 | 2020 | 11 | 0.160 |
Why?
|
| IMP Dehydrogenase | 1 | 2020 | 9 | 0.160 |
Why?
|
| Chromosome Mapping | 2 | 2015 | 297 | 0.160 |
Why?
|
| Antibodies, Monoclonal | 1 | 2025 | 875 | 0.160 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2017 | 38 | 0.160 |
Why?
|
| Acetylmuramyl-Alanyl-Isoglutamine | 3 | 2009 | 10 | 0.160 |
Why?
|
| CD11 Antigens | 1 | 2020 | 16 | 0.160 |
Why?
|
| Linezolid | 1 | 2020 | 7 | 0.160 |
Why?
|
| Penicillin-Binding Proteins | 2 | 2022 | 9 | 0.160 |
Why?
|
| Bayes Theorem | 3 | 2017 | 127 | 0.160 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2023 | 679 | 0.160 |
Why?
|
| Plasmids | 3 | 2018 | 294 | 0.160 |
Why?
|
| Cytokinesis | 1 | 2020 | 41 | 0.160 |
Why?
|
| Lymphocyte Depletion | 1 | 2020 | 96 | 0.160 |
Why?
|
| Gene Deletion | 2 | 2019 | 312 | 0.160 |
Why?
|
| Antigens, CD34 | 1 | 2000 | 53 | 0.160 |
Why?
|
| Amino Acid Sequence | 4 | 2015 | 1589 | 0.160 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2020 | 62 | 0.160 |
Why?
|
| Immunophenotyping | 1 | 2020 | 194 | 0.150 |
Why?
|
| Immunity | 1 | 2020 | 107 | 0.150 |
Why?
|
| Genetic Vectors | 4 | 2018 | 929 | 0.150 |
Why?
|
| Multigene Family | 1 | 2000 | 106 | 0.150 |
Why?
|
| Cytoplasm | 3 | 2016 | 283 | 0.150 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 179 | 0.150 |
Why?
|
| Rhodococcus | 2 | 2009 | 2 | 0.140 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2018 | 18 | 0.140 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2019 | 60 | 0.140 |
Why?
|
| Endothelium, Lymphatic | 1 | 1998 | 5 | 0.140 |
Why?
|
| Protein Transport | 1 | 2019 | 405 | 0.140 |
Why?
|
| Lymphatic System | 1 | 1998 | 19 | 0.140 |
Why?
|
| CRISPR-Cas Systems | 2 | 2025 | 369 | 0.140 |
Why?
|
| Reproducibility of Results | 4 | 2024 | 1715 | 0.140 |
Why?
|
| Caspase 1 | 1 | 2018 | 115 | 0.140 |
Why?
|
| Vaccines, Attenuated | 1 | 2018 | 35 | 0.140 |
Why?
|
| Drug Resistance, Microbial | 2 | 2019 | 47 | 0.130 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 2 | 2009 | 84 | 0.130 |
Why?
|
| Asymmetric Cell Division | 1 | 2017 | 5 | 0.130 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 170 | 0.130 |
Why?
|
| Crystallography, X-Ray | 2 | 2016 | 414 | 0.130 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 74 | 0.130 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2017 | 8 | 0.130 |
Why?
|
| Arachidonate 12-Lipoxygenase | 1 | 2017 | 13 | 0.130 |
Why?
|
| Recombination, Genetic | 1 | 2018 | 256 | 0.130 |
Why?
|
| Epistasis, Genetic | 1 | 2017 | 44 | 0.130 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 116 | 0.130 |
Why?
|
| Membrane Proteins | 3 | 2016 | 926 | 0.120 |
Why?
|
| Animals, Outbred Strains | 1 | 2016 | 7 | 0.120 |
Why?
|
| N-Acetylmuramoyl-L-alanine Amidase | 1 | 2016 | 4 | 0.120 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 371 | 0.120 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2016 | 6 | 0.120 |
Why?
|
| Endonucleases | 1 | 2017 | 84 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 206 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 733 | 0.120 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2017 | 241 | 0.120 |
Why?
|
| Down-Regulation | 1 | 2017 | 324 | 0.120 |
Why?
|
| Membrane Microdomains | 1 | 2016 | 51 | 0.120 |
Why?
|
| Metals | 1 | 2016 | 65 | 0.120 |
Why?
|
| Nickel | 2 | 2013 | 67 | 0.120 |
Why?
|
| Protein Domains | 1 | 2016 | 155 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2014 | 344 | 0.110 |
Why?
|
| Carbamazepine | 1 | 2015 | 10 | 0.110 |
Why?
|
| Oxidoreductases | 1 | 2015 | 61 | 0.110 |
Why?
|
| Sulfhydryl Compounds | 1 | 2015 | 52 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 1567 | 0.110 |
Why?
|
| Protein Binding | 3 | 2014 | 1636 | 0.110 |
Why?
|
| Homologous Recombination | 1 | 2015 | 30 | 0.110 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 446 | 0.110 |
Why?
|
| Markov Chains | 1 | 2015 | 37 | 0.110 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2014 | 22 | 0.110 |
Why?
|
| Electroporation | 1 | 2015 | 36 | 0.110 |
Why?
|
| Biomarkers | 1 | 2020 | 1487 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2012 | 364 | 0.100 |
Why?
|
| Siderophores | 2 | 2024 | 12 | 0.100 |
Why?
|
| Gene Silencing | 1 | 2017 | 436 | 0.100 |
Why?
|
| Molecular Biology | 1 | 2014 | 65 | 0.100 |
Why?
|
| Site-Specific DNA-Methyltransferase (Adenine-Specific) | 1 | 2013 | 36 | 0.100 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 95 | 0.100 |
Why?
|
| Cells, Cultured | 3 | 2012 | 2193 | 0.100 |
Why?
|
| Protein Modification, Translational | 1 | 2012 | 6 | 0.100 |
Why?
|
| Cation Transport Proteins | 1 | 2013 | 22 | 0.090 |
Why?
|
| Trans-Activators | 1 | 2014 | 321 | 0.090 |
Why?
|
| Acetyltransferases | 1 | 2012 | 27 | 0.090 |
Why?
|
| Acyl Coenzyme A | 1 | 2012 | 9 | 0.090 |
Why?
|
| Pyruvic Acid | 1 | 2012 | 16 | 0.090 |
Why?
|
| Software | 1 | 2015 | 401 | 0.090 |
Why?
|
| Folic Acid | 2 | 2019 | 42 | 0.090 |
Why?
|
| Enzymes | 1 | 2012 | 35 | 0.090 |
Why?
|
| Protein Multimerization | 1 | 2012 | 181 | 0.090 |
Why?
|
| Cyclic AMP | 1 | 2012 | 144 | 0.090 |
Why?
|
| Cell Membrane | 1 | 2014 | 506 | 0.090 |
Why?
|
| Ethambutol | 1 | 2011 | 4 | 0.090 |
Why?
|
| Anaerobiosis | 1 | 2011 | 14 | 0.090 |
Why?
|
| Phagosomes | 2 | 2024 | 44 | 0.090 |
Why?
|
| Biosynthetic Pathways | 1 | 2011 | 17 | 0.090 |
Why?
|
| Isoniazid | 1 | 2011 | 13 | 0.090 |
Why?
|
| Acetyl Coenzyme A | 1 | 2011 | 23 | 0.080 |
Why?
|
| Citric Acid Cycle | 1 | 2011 | 29 | 0.080 |
Why?
|
| Substrate Specificity | 3 | 2019 | 344 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2013 | 306 | 0.080 |
Why?
|
| Chromatography, Gas | 1 | 2011 | 8 | 0.080 |
Why?
|
| Phylogeny | 3 | 2023 | 399 | 0.080 |
Why?
|
| Automation | 1 | 2011 | 55 | 0.080 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2012 | 263 | 0.080 |
Why?
|
| Infant | 2 | 2025 | 1711 | 0.080 |
Why?
|
| Spleen | 1 | 2011 | 476 | 0.080 |
Why?
|
| Conserved Sequence | 1 | 2010 | 173 | 0.080 |
Why?
|
| Triglycerides | 1 | 2011 | 248 | 0.080 |
Why?
|
| Dendritic Cells | 2 | 2025 | 531 | 0.070 |
Why?
|
| Sialoglycoproteins | 2 | 2000 | 20 | 0.070 |
Why?
|
| Interferon Regulatory Factors | 1 | 2009 | 43 | 0.070 |
Why?
|
| Thiostrepton | 1 | 2009 | 1 | 0.070 |
Why?
|
| Cell Line | 4 | 2021 | 2030 | 0.070 |
Why?
|
| Streptomyces | 1 | 2009 | 15 | 0.070 |
Why?
|
| Models, Biological | 1 | 2014 | 1193 | 0.070 |
Why?
|
| Inflammasomes | 1 | 2012 | 352 | 0.070 |
Why?
|
| Bacteriological Techniques | 1 | 2008 | 29 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2025 | 1144 | 0.070 |
Why?
|
| Epitopes | 2 | 2019 | 291 | 0.070 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2008 | 100 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 514 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2008 | 351 | 0.060 |
Why?
|
| Adjuvants, Immunologic | 1 | 2007 | 237 | 0.060 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2026 | 89 | 0.060 |
Why?
|
| Necrosis | 2 | 2020 | 148 | 0.060 |
Why?
|
| Forecasting | 1 | 2007 | 231 | 0.060 |
Why?
|
| Transformation, Bacterial | 1 | 2005 | 12 | 0.060 |
Why?
|
| Homeodomain Proteins | 2 | 2022 | 277 | 0.060 |
Why?
|
| Risk Factors | 1 | 2016 | 5466 | 0.060 |
Why?
|
| Biological Transport | 2 | 2017 | 292 | 0.060 |
Why?
|
| Clofazimine | 1 | 2025 | 5 | 0.060 |
Why?
|
| CD40 Antigens | 1 | 2025 | 59 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2005 | 252 | 0.060 |
Why?
|
| Administration, Intranasal | 1 | 2025 | 29 | 0.060 |
Why?
|
| B7-H1 Antigen | 1 | 2025 | 60 | 0.050 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2024 | 9 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2008 | 744 | 0.050 |
Why?
|
| Aminosalicylic Acid | 1 | 2004 | 1 | 0.050 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 2 | 2020 | 8 | 0.050 |
Why?
|
| Quality Control | 1 | 2024 | 79 | 0.050 |
Why?
|
| NADPH Oxidases | 1 | 2024 | 69 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 3 | 2013 | 672 | 0.050 |
Why?
|
| Protein Conformation | 2 | 2021 | 791 | 0.050 |
Why?
|
| Drug Resistance, Multiple | 1 | 2004 | 28 | 0.050 |
Why?
|
| Species Specificity | 1 | 2025 | 344 | 0.050 |
Why?
|
| Multiprotein Complexes | 1 | 2005 | 156 | 0.050 |
Why?
|
| Salmonella typhimurium | 1 | 2024 | 86 | 0.050 |
Why?
|
| Disulfides | 1 | 2024 | 67 | 0.050 |
Why?
|
| Streptozocin | 1 | 2023 | 23 | 0.050 |
Why?
|
| Heme | 1 | 2023 | 30 | 0.050 |
Why?
|
| Mice, Inbred DBA | 1 | 2023 | 84 | 0.050 |
Why?
|
| Glycerol | 1 | 2023 | 34 | 0.050 |
Why?
|
| Genetic Background | 1 | 2023 | 7 | 0.050 |
Why?
|
| Genetic Loci | 1 | 2024 | 117 | 0.050 |
Why?
|
| Oligosaccharides | 1 | 2003 | 55 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2003 | 301 | 0.050 |
Why?
|
| Tyrosine | 1 | 2003 | 93 | 0.050 |
Why?
|
| Endothelium, Vascular | 2 | 2003 | 179 | 0.050 |
Why?
|
| Drug Carriers | 1 | 2025 | 190 | 0.050 |
Why?
|
| Jurkat Cells | 2 | 2003 | 109 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2025 | 517 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 93 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2025 | 625 | 0.050 |
Why?
|
| NF-kappa B | 2 | 2018 | 435 | 0.050 |
Why?
|
| Virus Replication | 1 | 2003 | 323 | 0.040 |
Why?
|
| Mammals | 1 | 2023 | 222 | 0.040 |
Why?
|
| Palatine Tonsil | 2 | 1999 | 10 | 0.040 |
Why?
|
| Binding Sites | 2 | 2016 | 921 | 0.040 |
Why?
|
| Interleukin-12 | 1 | 2022 | 127 | 0.040 |
Why?
|
| Mice, SCID | 2 | 2017 | 518 | 0.040 |
Why?
|
| Culture Media | 1 | 2001 | 78 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2022 | 165 | 0.040 |
Why?
|
| Cellular Reprogramming | 1 | 2021 | 41 | 0.040 |
Why?
|
| Sex Determination Processes | 1 | 2020 | 11 | 0.040 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2020 | 9 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 129 | 0.040 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2021 | 219 | 0.040 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2020 | 26 | 0.040 |
Why?
|
| Sialomucins | 1 | 2000 | 1 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2003 | 351 | 0.040 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2000 | 16 | 0.040 |
Why?
|
| Chondroitin Sulfates | 1 | 2000 | 11 | 0.040 |
Why?
|
| Binomial Distribution | 1 | 2019 | 4 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2020 | 98 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2020 | 237 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2020 | 199 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2019 | 69 | 0.040 |
Why?
|
| Chemokines, CX3C | 1 | 1999 | 3 | 0.040 |
Why?
|
| Topoisomerase II Inhibitors | 1 | 2019 | 9 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2000 | 292 | 0.040 |
Why?
|
| Chemokines, CXC | 1 | 1999 | 33 | 0.040 |
Why?
|
| DNA Gyrase | 1 | 2019 | 10 | 0.040 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2021 | 350 | 0.040 |
Why?
|
| Tryptophan | 1 | 2019 | 56 | 0.040 |
Why?
|
| Pandemics | 1 | 2024 | 691 | 0.040 |
Why?
|
| Kinetics | 1 | 2020 | 757 | 0.040 |
Why?
|
| Proteomics | 2 | 2015 | 299 | 0.040 |
Why?
|
| Linear Models | 1 | 2019 | 405 | 0.040 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinase 2 | 2 | 2009 | 9 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 129 | 0.040 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1998 | 15 | 0.040 |
Why?
|
| Chromosomes | 1 | 2019 | 139 | 0.030 |
Why?
|
| Appendix | 1 | 1998 | 17 | 0.030 |
Why?
|
| Ubiquitin | 2 | 2009 | 104 | 0.030 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2018 | 20 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2017 | 21 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2025 | 3329 | 0.030 |
Why?
|
| Cell Size | 1 | 2017 | 41 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 1998 | 199 | 0.030 |
Why?
|
| Immunization | 1 | 2018 | 135 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2017 | 61 | 0.030 |
Why?
|
| PPAR gamma | 1 | 2017 | 77 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2017 | 115 | 0.030 |
Why?
|
| Streptococcus thermophilus | 1 | 2017 | 3 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2017 | 124 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2017 | 102 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 97 | 0.030 |
Why?
|
| Streptococcus pyogenes | 1 | 2017 | 30 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2017 | 47 | 0.030 |
Why?
|
| Genetic Techniques | 1 | 2017 | 39 | 0.030 |
Why?
|
| Sulfasalazine | 1 | 2016 | 5 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2017 | 197 | 0.030 |
Why?
|
| X-Ray Absorption Spectroscopy | 1 | 2016 | 15 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2020 | 1044 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2017 | 267 | 0.030 |
Why?
|
| Foam Cells | 1 | 2015 | 5 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2018 | 239 | 0.030 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2017 | 100 | 0.030 |
Why?
|
| Programming Languages | 1 | 2015 | 13 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2017 | 143 | 0.030 |
Why?
|
| Pattern Recognition, Automated | 1 | 2015 | 52 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2015 | 35 | 0.030 |
Why?
|
| Lipid Droplets | 1 | 2015 | 35 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 328 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2015 | 89 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 269 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 2016 | 154 | 0.030 |
Why?
|
| Reactive Nitrogen Species | 1 | 2013 | 9 | 0.030 |
Why?
|
| Polyketide Synthases | 1 | 2013 | 2 | 0.030 |
Why?
|
| Thioredoxins | 1 | 2013 | 17 | 0.030 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2013 | 37 | 0.020 |
Why?
|
| Codon, Initiator | 1 | 2013 | 11 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2009 | 869 | 0.020 |
Why?
|
| Microbial Viability | 1 | 2013 | 56 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2013 | 130 | 0.020 |
Why?
|
| Point Mutation | 1 | 2013 | 169 | 0.020 |
Why?
|
| Cations, Divalent | 1 | 2012 | 25 | 0.020 |
Why?
|
| Acetylation | 1 | 2012 | 121 | 0.020 |
Why?
|
| Child | 1 | 2022 | 4634 | 0.020 |
Why?
|
| Threonine | 1 | 2012 | 15 | 0.020 |
Why?
|
| Lysine | 1 | 2012 | 93 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2012 | 103 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2012 | 105 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 1573 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2012 | 198 | 0.020 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2011 | 11 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2011 | 31 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 48 | 0.020 |
Why?
|
| Cathepsins | 1 | 2011 | 34 | 0.020 |
Why?
|
| Cell Adhesion | 2 | 2003 | 218 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2011 | 111 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2011 | 146 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 139 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 225 | 0.020 |
Why?
|
| Laboratories | 1 | 2010 | 27 | 0.020 |
Why?
|
| Genome | 1 | 2012 | 286 | 0.020 |
Why?
|
| Glycols | 1 | 2009 | 2 | 0.020 |
Why?
|
| Actinobacteria | 1 | 2009 | 8 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2011 | 465 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 2009 | 19 | 0.020 |
Why?
|
| Models, Immunological | 1 | 2009 | 85 | 0.020 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2009 | 98 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2009 | 115 | 0.020 |
Why?
|
| Research | 1 | 2010 | 195 | 0.020 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2007 | 27 | 0.020 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2007 | 24 | 0.020 |
Why?
|
| I-kappa B Kinase | 1 | 2007 | 50 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2009 | 301 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2007 | 83 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 80 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2007 | 203 | 0.020 |
Why?
|
| Apoptosis | 1 | 2011 | 1100 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2007 | 434 | 0.010 |
Why?
|
| Folic Acid Antagonists | 1 | 2004 | 9 | 0.010 |
Why?
|
| Adult | 1 | 2022 | 17511 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 611 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2005 | 296 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 77 | 0.010 |
Why?
|
| Carbohydrate Metabolism | 1 | 2003 | 49 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 165 | 0.010 |
Why?
|
| Dimerization | 1 | 2003 | 145 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 180 | 0.010 |
Why?
|
| CHO Cells | 1 | 2003 | 193 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2011 | 1561 | 0.010 |
Why?
|
| Cricetinae | 1 | 2003 | 362 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 700 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 503 | 0.010 |
Why?
|
| Langerhans Cells | 1 | 1999 | 11 | 0.010 |
Why?
|
| Chemokine CX3CL1 | 1 | 1999 | 7 | 0.010 |
Why?
|
| CD40 Ligand | 1 | 1999 | 159 | 0.010 |
Why?
|
| DNA Primers | 1 | 1999 | 302 | 0.010 |
Why?
|
| Cell Communication | 1 | 1999 | 135 | 0.010 |
Why?
|
| Melanocytes | 1 | 1999 | 77 | 0.010 |
Why?
|
| Up-Regulation | 1 | 1999 | 376 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1999 | 604 | 0.010 |
Why?
|
| Skin | 1 | 1999 | 436 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1999 | 1389 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1999 | 1581 | 0.010 |
Why?
|